Hypothesis

Aging desynchronizes the phosphorylation‑dependent activation timing of selective autophagy receptors (SARs), causing the canonical hierarchy of organelle consumption to shift out of phase with metabolic demand. This mistimed selectivity leads to preferential clearance of less‑critical substrates while damaged mitochondria persist, driving age‑associated decline.

Mechanistic Basis

• SARs such as Atg32 (mitochondria) and Atg30 (peroxisomes) require upstream kinase‑dependent phosphorylation before they can bind Atg11 scaffolds and recruit autophagosomes[1]
• Ubiquitin‑dependent receptors like p62/SQSTM1 use dual UBA and LIR domains to link ubiquitinated cargo to LC3[2]
• In young cells, nutrient‑sensing kinases (AMPK, ULK1, TBK1) generate a rapid, high‑amplitude phosphorylation pulse that preferentially activates mitochondrial SARs during early starvation, establishing a temporally ordered "triage" where mitochondria are cleared before ER or protein aggregates
• With age, the amplitude and kinetics of these kinase pulses dampen, flattening the activation landscape. Consequently, SARs with lower activation thresholds (e.g., ER‑phagy receptors) fire first, while high‑threshold mitochondrial SARs are delayed or missed[3]
• The resulting hierarchy inversion means that limited autophagosomal capacity is expended on substrates that are less critical for immediate survival, allowing damaged mitochondria to accumulate ROS and further impair kinase signaling—a vicious cycle

Novel Mechanistic Insight

We propose that the age‑related shift is not merely a loss of overall autophagy capacity but a phase‑desynchronization of the SAR activation network. Restoring the original temporal order—by pharmacologically boosting the early‑phase kinase pulse specifically for mitochondrial SARs—should re‑establish the correct triage order without changing total autophagosome number.

Testable Predictions

1. In young mouse liver, phospho‑specific immunoblots will show a sharp early peak (within 15 min of fasting) of phosphorylated Atg32 that precedes peaks of phosphorylated FAM134B (ER‑phagy) and p62
2. In aged mice (≥24 mo), the Atg32 phosphorylation peak will be delayed (>45 min) and reduced in amplitude, while ER‑phagy SAR phosphorylation occurs earlier relative to the fasting onset
3. Mitochondrial ROS levels and membrane potential loss will correlate inversely with the timing of Atg32 activation across individual hepatocytes
4. Acute activation of AMPK with a short‑acting agonist (e.g., AICAR bolus) administered at the onset of fasting will rescue the early Atg32 phosphorylation peak in aged mice, restoring mitochondrial clearance rates to youthful levels
5. Genetic knockdown of ER‑phagy receptor FAM134B in aged mice will not improve mitochondrial health unless the early Atg32 activation timing is also corrected, indicating that hierarchy, not receptor abundance, dictates outcome

Experimental Design

• Model: C57BL/6 mice, young (3 mo) vs aged (24 mo). Primary hepatocytes isolated for live‑cell imaging
• Readouts:
  • Phospho‑specific antibodies for Atg32 (Ser114), FAM134B (SerXX), p62 (Ser403) measured by Western blot and flow cytometry at 0, 15, 30, 60, 120 min after a 4‑h fast
  • Mitochondrial autophagy flux using mt‑Keima reporter
  • ER‑phagy flux using FAM134B‑GFP‑LC3 assay
  • Mitochondrial ROS (MitoSOX) and membrane potential (TMRE)
• Interventions:
  • AICAR bolus (250 mg/kg i.p.) given at fasting start
  • Control: saline
  • Optional: AAV‑shRNA against FAM134B
• Analysis: Compare phosphorylation kinetics (time to half‑max, area under curve) between groups; test whether AICAR normalizes the Atg32 peak without altering total LC3‑II conversion

Potential Outcomes & Falsification

• Supported: Aged mice show delayed Atg32 phosphorylation; AICAR restores early peak and mitochondrial flux; ER‑phagy knockdown alone fails to rescue mitochondrial health
• Falsified: No age‑dependent difference in SAR phosphorylation timing, or AICAR fails to shift Atg32 kinetics despite increasing overall autophagy, indicating that hierarchy is not the limiting factor

If the hypothesis holds, it reframes age‑related autophagy decline as a timing disorder rather than a capacity loss, opening therapeutic avenues that target kinase signaling dynamics to reinstate the cell’s internal triage system